AAK1 inhibitors (Bristol-Myers Squibb/Syngene International/Lexicon Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAAK1 inhibitors (Bristol-Myers Squibb/Syngene International/Lexicon Pharmaceuticals)
Drug Alias NameBMS-911172BMS-23
ClassificationSmall molecules
Mechanisms of ActionAP2-associated protein kinase 1 inhibitors
TargetsAP2-associated protein kinase 1
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyngene International LtdBristol-Myers Squibb CompanyLexicon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A